Luksika Jiramonai | Biochemistry, Genetics and Molecular Biology | Young Scientist Award

Posted on by ScienceFather

Ms. Luksika Jiramonai | Biochemistry, Genetics and Molecular Biology | Young Scientist Award

phD at National Center for Nanoscience and Technology, China

Luksika Jiramonai is a dedicated researcher in the fields of nanoscience, biotechnology, and biomedical sciences. Currently a PhD student at the National Center for Nanoscience and Technology, University of Chinese Academy of Sciences, Beijing, China, her work focuses on advancing therapeutic and diagnostic strategies in health sciences. She has a strong academic foundation with a Master’s degree in Applied Biological Sciences from Chulabhorn Graduate Institute, Thailand, and a Bachelor’s degree in Biotechnology from Mahidol University, Thailand. Over the years, Luksika has demonstrated a passion for applying her research in practical and transformative ways, particularly in the areas of disease resistance, nanotechnology, and molecular biology. With extensive research experience and an impressive track record of publications and awards, she is emerging as a promising scientist committed to solving global health challenges through innovation and scientific rigor.

Professional Profile

Education

Luksika Jiramonai has an impressive academic background, beginning with a Bachelor of Science in Biotechnology from Mahidol University, Thailand, where she explored molecular and bioprocess applications in biotechnology. She further pursued a Master of Science in Applied Biological Sciences at Chulabhorn Graduate Institute, Thailand, graduating with a cumulative GPA of 3.67/4.00. Her thesis, focused on oxidative stress responses in Stenotrophomonas maltophilia, showcases her early interest in microbiology and biotechnology. Building on this foundation, she is currently pursuing a PhD at the National Center for Nanoscience and Technology, University of Chinese Academy of Sciences, China. Her academic journey reflects a strong focus on interdisciplinary research with an emphasis on the intersection of molecular biology, nanotechnology, and medicine. This diverse education provides a solid platform for her ongoing contributions to the field.

Professional Experience

Luksika has accumulated diverse and extensive professional experience throughout her career. From 2019 to 2022, she worked as a Research Laboratory Technician at the Malaria Laboratory, Mahidol-Oxford Research Unit, where she investigated malaria and drug resistance, playing a key role in essential research aimed at combating infectious diseases. Prior to that, she served as a Research Assistant at the Molecular Clinical Pathology Laboratory, Department of Clinical Pathology at Siriraj Hospital, Thailand, where she contributed to projects focusing on cancer and oncolytic viruses. Luksika also held a position as a Research Assistant at Chulabhorn Graduate Institute, Thailand, contributing to research on bacterial oxidative stress and antibiotic resistance. Her early experience includes an internship at SGS Thailand, where she performed standardized testing on environmental and food samples. This broad range of experience underscores her adaptability and expertise in various biomedical research areas.

Research Interests

Luksika Jiramonai’s research interests center on molecular biology, nanotechnology, and their applications in healthcare. Her current PhD research delves into the development of nanoscience-based therapeutic strategies, particularly in cancer immunotherapy and drug resistance. She has explored a variety of critical scientific fields, including bacterial oxidative stress, drug resistance mechanisms in infectious diseases like malaria, and the application of nanocrystals in drug delivery systems. Additionally, her work on atherosclerosis models and their pathophysiology demonstrates her broad interest in chronic diseases and their biomedical implications. Luksika’s interdisciplinary approach integrates molecular biology with advanced nanotechnology, and her goal is to develop more targeted, effective treatments for complex health issues. Her research aims to bridge the gap between laboratory findings and real-world medical applications, contributing to better patient outcomes through innovative scientific discoveries.

Awards and Honors

Luksika Jiramonai has received notable recognition for her contributions to scientific research. She was honored with an honorable mention at the 8th Annual Conference on “Trends in Research on Environmental Health” in Thailand, underscoring the relevance of her research in environmental health. In 2018, she was a shortlisted candidate for poster presentation at the prestigious Thailand Merck Young Scientist Award, highlighting her potential as an emerging scientist. More recently, she has authored several review articles and research papers published in respected journals such as Pharmaceutics, iScience, and Antonie van Leeuwenhoek. Her research on nanocrystals, tumor immunotherapy, and atherosclerosis models has further established her as a rising star in the scientific community. These achievements underscore her commitment to advancing science and her recognition as a researcher capable of making significant impacts in biomedical research.

Conclusion

Luksika Jiramonai appears highly suitable for the Research for Young Scientist Award. She has demonstrated strong academic credentials, significant research experience, and published work that is relevant to important health challenges. Her background in interdisciplinary research on malaria, cancer, drug resistance, and nanotechnology positions her as a promising scientist for the future.

Publications Top Noted

  • Title: Extracellular Vesicle-Based Strategies for Tumor Immunotherapy
    Authors: Luksika Jiramonai, Xing-Jie Liang, Mengliang Zhu
    Year: 2025
    Journal: Pharmaceutics
    DOI: 10.3390/pharmaceutics17020257
    Citation: Jiramonai, L., Liang, X.-J., & Zhu, M. (2025). Extracellular Vesicle-Based Strategies for Tumor Immunotherapy. Pharmaceutics, 17(2), 257. https://doi.org/10.3390/pharmaceutics17020257

  • Title: The Development of Paliperidone Nanocrystals for the Treatment of Schizophrenia
    Authors: Phattalapol Lhaglham, Luksika Jiramonai, Xing-Jie Liang, Bingchuan Liu, Fangzhou Li
    Year: 2025
    Journal: Progress in Biomedical Engineering
    DOI: 10.1088/2516-1091/ad8fe7
    Citation: Lhaglham, P., Jiramonai, L., Liang, X.-J., Liu, B., & Li, F. (2025). The Development of Paliperidone Nanocrystals for the Treatment of Schizophrenia. Progress in Biomedical Engineering, 1(1), ad8fe7. https://doi.org/10.1088/2516-1091/ad8fe7

  • Title: Drug Nanocrystals: Surface Engineering and Its Applications in Targeted Delivery
    Authors: Phattalapol Lhaglham, Luksika Jiramonai, Yaru Jia, Baoying Huang, Yuanyu Huang, Xueyun Gao, Jinchao Zhang, Xing-Jie Liang, Mengliang Zhu
    Year: 2024
    Journal: iScience
    DOI: 10.1016/j.isci.2024.111185
    Citation: Lhaglham, P., Jiramonai, L., Jia, Y., Huang, B., Huang, Y., Gao, X., Zhang, J., Liang, X.-J., & Zhu, M. (2024). Drug Nanocrystals: Surface Engineering and Its Applications in Targeted Delivery. iScience, 11, 111185. https://doi.org/10.1016/j.isci.2024.111185

  • Title: Inactivation of ahpC Renders Stenotrophomonas maltophilia Resistant to the Disinfectant Hydrogen Peroxide
    Authors: Nisanart Charoenlap, Luksika Jiramonai, Jurairat Chittrakanwong, Naruemon Tunsakul, Skorn Mongkolsuk, Paiboon Vattanaviboon
    Year: 2019
    Journal: Antonie van Leeuwenhoek
    DOI: 10.1007/s10482-018-1203-9
    Citation: Charoenlap, N., Jiramonai, L., Chittrakanwong, J., Tunsakul, N., Mongkolsuk, S., & Vattanaviboon, P. (2019). Inactivation of ahpC Renders Stenotrophomonas maltophilia Resistant to the Disinfectant Hydrogen Peroxide. Antonie van Leeuwenhoek, 112(5), 757-764. https://doi.org/10.1007/s10482-018-1203-9

 

Harry Jarrett | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Posted on by ScienceFather

Dr. Harry Jarrett | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Head of Science and Research at Heights, United Kingdom

Dr. Harry Jarrett is a passionate scientist with a focus on nutritional research, particularly in the context of chronic disease prevention. He believes that optimizing nutrition can significantly reduce the risk of prevalent health issues. With a PhD in Nutritional Sciences from Ulster University and a strong academic background, Dr. Jarrett has combined clinical and research expertise to contribute to the field of nutrition. His work spans various roles, including his current position as Head of Science and Research at Heights, where he leads human intervention trials and drives product development. Additionally, Dr. Jarrett has substantial experience in the medical field, including his work as a COVID-19 Research Laboratory Coordinator during the pandemic. His career is a testament to his commitment to advancing nutrition science and its real-world applications, striving to make significant contributions to improving public health through research and innovation.

Professional Profile

Education

Dr. Jarrett completed his PhD in Nutritional Sciences at the Nutrition Innovation Centre for Food and Health at Ulster University, where he focused on gene-environment interactions in blood pressure and stroke risk. His thesis investigated how riboflavin can lower systolic blood pressure, a significant finding in hypertension research. Prior to his PhD, he earned a Master’s degree in Exercise and Health Sciences from the University of Exeter, with a focus on nutrition’s impact on mental health and neurodegenerative diseases. Dr. Jarrett also completed a Bachelor’s degree in Exercise and Sport Sciences from the University of Exeter, graduating with first-class honors. His academic journey has been marked by strong achievements, including a postgraduate scholarship, distinction profile, and recognition for his contributions to research. Throughout his education, Dr. Jarrett has demonstrated a deep commitment to exploring the intersections between nutrition, health, and disease prevention.

Professional Experience

Dr. Jarrett’s professional experience spans several prestigious institutions and roles. Currently, he serves as Head of Science and Research at Heights, where he is responsible for the strategic direction and execution of research projects, including human intervention trials focused on nutrition and health. He also coordinates the translation of scientific findings into products and marketing strategies. From 2021 to 2024, Dr. Jarrett worked as a COVID-19 Research Laboratory Coordinator at Guy’s and St Thomas’ NHS Trust, where he managed clinical trials during the pandemic and was responsible for writing protocols, securing ethical approvals, and overseeing research quality. He also held a postdoctoral position at the NNEdPro Global Institute for Food and Nutrition Research, where he led investigations into cardiovascular disease risk factors using data from the UK Biobank. Additionally, Dr. Jarrett has contributed to academia by mentoring students and delivering lectures on nutrition and B-vitamin biochemistry.

Research Interests

Dr. Jarrett’s primary research interest lies in the relationship between nutrition and chronic disease prevention, with a particular focus on cardiovascular health and blood pressure regulation. His work has explored how micronutrients, especially B-vitamins like riboflavin, can impact blood pressure and metabolic function, offering new avenues for non-pharmacological interventions. His PhD research focused on understanding gene-environment interactions, specifically how certain genetic variations can influence an individual’s response to nutritional interventions. Dr. Jarrett is also interested in how nutrition can mitigate the effects of age-related diseases, including neurodegenerative conditions and mental health disorders. His ongoing research involves human intervention trials to assess the efficacy of nutritional supplements in improving health outcomes. Additionally, he is involved in investigating large datasets, such as those from the UK Biobank, to uncover insights into the broader epidemiological relationships between diet and health.

Awards and Honors

Dr. Harry Jarrett has received numerous accolades throughout his academic and professional career, reflecting his exceptional research contributions. Notably, he was awarded the Best Poster award at the Federation of American Societies for Experimental Biology (FASEB) conference for his work on folic acid and one-carbon metabolism. He also earned the Broadening Horizons Travel Bursary from Ulster University and a top-ranking young investigator abstract at the British and Irish Hypertension Society conference. Dr. Jarrett’s commitment to research excellence has earned him recognition from his peers and colleagues. His PhD research, published in the American Journal of Clinical Nutrition, has been widely cited and demonstrates his capacity to contribute to significant scientific advancements. Additionally, he has received honors such as the Postgraduate Commendation from the University of Exeter, further acknowledging his academic excellence and dedication to the field of nutrition science.

Conclusion

Dr. Harry Jarrett is a well-rounded and accomplished researcher with a clear impact in the field of nutrition science. His combination of robust academic background, hands-on clinical experience, leadership in research, and commitment to advancing public health makes him a highly suitable candidate for the Best Researcher Award. By enhancing his cross-disciplinary collaborations and expanding the visibility of his research, Dr. Jarrett has the potential to make even greater contributions to the field in the future.

Publications Top Noted

  • The Role of the Gut Microbiome and Probiotics in Sports Performance: A Narrative Review Update

    • Author(s): Harry Jarrett, Sophie Medlin, James C. Morehen
    • Year: 2025
    • Citation: Jarrett H, Medlin S, Morehen JC. The Role of the Gut Microbiome and Probiotics in Sports Performance: A Narrative Review Update. Nutrients. 2025;17(4):690. doi: 10.3390/nu17040690.

  • Survival of Probiotic Bacterial Cells in the Upper Gastrointestinal Tract and the Effect of the Surviving Population on the Colonic Microbial Community Activity and Composition

    • Author(s): Marlies Govaert, ChloĂ« Rotsaert, Chelsea Vannieuwenhuyse, Cindy Duysburgh, Sophie Medlin, Massimo Marzorati, Harry Jarrett
    • Year: 2024
    • Citation: Govaert M, Rotsaert C, Vannieuwenhuyse C, Duysburgh C, Medlin S, Marzorati M, Jarrett H. Survival of Probiotic Bacterial Cells in the Upper Gastrointestinal Tract and the Effect of the Surviving Population on the Colonic Microbial Community Activity and Composition. Nutrients. 2024;16(8):2791. doi: 10.3390/nu16162791.

  • Magnesium in Human Health and Disease: A Review of Our Current Understanding

    • Author(s): Harry Jarrett, Ryan McNally, Anna Hernández-Rubio, Sally Brett, Luca Faconti
    • Year: 2024
    • Citation: Jarrett H, McNally R, Hernández-Rubio A, Brett S, Faconti L. Magnesium in Human Health and Disease: A Review of Our Current Understanding. EC Nutrition. 2024;23(7):2303-2315.

  • Association of dietary flavan-3-ol intakes with plasma phenyl-Îł-valerolactones: analysis from the TUDA cohort of healthy older adults

    • Author(s): Donato Angelino, Aoife Caffrey, Helene McNulty, Chris IR. Gill, Pedro Mena, Alice Rosi, Katie Moore, Leane Hoey, Michelle Clements, Eamon Laird, et al.
    • Year: 2023
    • Citation: Angelino D, Caffrey A, McNulty H, Gill CIR, Mena P, Rosi A, Moore K, Hoey L, Clements M, Laird E, et al. Association of dietary flavan-3-ol intakes with plasma phenyl-Îł-valerolactones: analysis from the TUDA cohort of healthy older adults. Am J Clin Nutr. 2023;118(2):426-438. doi: 10.1016/j.ajcnut.2023.06.006.

  • Vitamin B-6 and riboflavin, their metabolic interaction, and relationship with MTHFR genotype in adults aged 18-102 years

    • Author(s): Harry Jarrett, Helene McNulty, Catherine Hughes, Kristina Pentieva, James J. Strain, Anne Molloy, Aileen McCann, et al.
    • Year: 2022
    • Citation: Jarrett H, McNulty H, Hughes CF, Pentieva K, Strain JJ, Molloy A, McCann A, et al. Vitamin B-6 and riboflavin, their metabolic interaction, and relationship with MTHFR genotype in adults aged 18-102 years. Am J Clin Nutr. 2022;116(6):1422-1431. doi: 10.1093/ajcn/nqac240.

  • Validity of plasma phenyl-Îł-valerolactones as novel biomarkers of dietary (poly)phenols: Preliminary analysis from the VALID project

    • Author(s): B. Parmenter, K. Moore, D. Angelino, D. Del Rio, H. McNulty, A.M. Molloy, C. Cunningham, M. Ward, B. Pucci, H. Jarrett, et al.
    • Year: 2018
    • Citation: Parmenter B, Moore K, Angelino D, Del Rio D, McNulty H, Molloy AM, Cunningham C, Ward M, Pucci B, Jarrett H, et al. Validity of plasma phenyl-Îł-valerolactones as novel biomarkers of dietary (poly)phenols: Preliminary analysis from the VALID project. Proc Nutr Soc. 2018;77(3):234-243. doi: 10.1017/s0029665118001040.

  • Blood pressure and hypertension in relation to cognitive performance in older Irish adults from the TUDA cohort: Preliminary analysis

    • Author(s): Harry Jarrett
    • Year: 2018
    • Citation: Jarrett H. Blood pressure and hypertension in relation to cognitive performance in older Irish adults from the TUDA cohort: Preliminary analysis. J Hum Hypertens. 2018;32(5):319-326. doi: 10.1038/s41371-018-0089-5.

  • Effect of B-vitamin Supplementation on Cognitive Performance and Brain Function in The BrainHOP Trial

    • Author(s): Katie Moore, Catherine Hughes, Kirsty Porter, Leanne Doherty, Pramod Gaur, Fergal Tracey, Maurice O’Kane, Harry Jarrett, Mary Ward, Leanne Hoey
    • Year: 2018
    • Citation: Moore K, Hughes C, Porter K, Doherty L, Gaur P, Tracey F, O’Kane M, Jarrett H, Ward M, Hoey L. Effect of B-vitamin Supplementation on Cognitive Performance and Brain Function in The BrainHOP Trial. Age Ageing. 2018;47(5):702-710. doi: 10.1093/ageing/afy141.35.

 

Christopher Milton Mathew | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Posted on by ScienceFather

Prof. Dr. Christopher Milton Mathew | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Research Fellow at Franco Flinders University, Australia

Mariangela Di Vincenzo is an Italian biologist specializing in stem cell research, with a focus on the underlying mechanisms in Cushing’s syndrome and related disorders. Born on October 16, 1994, in Ancona, Italy, she has built a robust academic and professional trajectory within the scientific community. She currently serves as a research fellow at Marche Polytechnic University, where she is contributing to cutting-edge research in the field of human health, particularly involving stem cell dysfunctions in Cushing’s syndrome. Her academic journey and hands-on training have been instrumental in shaping her into a highly competent researcher. Her work has placed her at the intersection of molecular biology, histology, and clinical sciences, earning her recognition for her contributions to understanding complex pathologies and their cellular mechanisms. With a deep passion for science, she is positioning herself for significant contributions to medical advancements in the coming years.

Professional Profile

Education

Mariangela Di Vincenzo pursued her academic journey at Marche Polytechnic University in Italy, where she laid the foundation for her research career. She earned a Bachelor’s degree in Biological Sciences in 2017, followed by a Master’s degree in Molecular and Applied Biology in 2019, specializing in biological technologies. Her Master’s thesis focused on oxidative stress effects on embryo development in Danio Rerio, marking her first foray into experimental biology. Mariangela is currently completing her PhD in Human Health at Marche Polytechnic University under the supervision of Professors Monia Orciani and Giorgio Arnaldi, with her research dedicated to exploring mesenchymal stem cell dysfunctions in Cushing’s syndrome. The breadth of her education, coupled with specialized training in histology and medical technologies, has equipped her with a comprehensive understanding of biological systems and pathology, providing a strong foundation for her future academic and scientific endeavors.

Professional Experience

Mariangela’s professional career has been marked by significant research involvement at Marche Polytechnic University, where she has worked on several impactful research projects. Since November 2023, she has been a research fellow focusing on stem cell-based therapies for Cushing’s syndrome under the guidance of prominent professors in the field. Her role involves investigating the potential of stem cells as therapeutic targets in the treatment of complex diseases. Prior to this, she worked as a research fellow in 2020 on glucocorticoids and stem cells, further expanding her expertise in the dysregulated secretion of key molecules in various pathologies. Additionally, Mariangela has contributed to organizational roles in academic conferences, such as the GEISIBSC and SII Unified Conference in 2019. Her internships in histology and medically assisted reproduction have also refined her practical skills, making her well-versed in laboratory techniques and clinical research applications.

Research Interests

Mariangela Di Vincenzo’s research interests lie at the intersection of stem cell biology, endocrinology, and molecular pathology. Her primary focus is on understanding the dysfunctions of mesenchymal stem cells in Cushing’s syndrome, a condition characterized by the overproduction of cortisol. She is particularly interested in how stem cells respond to glucocorticoid-induced stress and their role in disease progression. Through her PhD work, she aims to uncover new therapeutic approaches by targeting stem cells as potential treatments for conditions associated with cortisol dysregulation. Additionally, her research delves into the broader impacts of oxidative stress on cellular development and the molecular pathways involved in stem cell differentiation and dysfunction. By exploring these areas, Mariangela aspires to contribute to new diagnostic and therapeutic strategies in the treatment of endocrine disorders and other related diseases.

Awards and Honors

While Mariangela’s career is still in the early stages, her potential has already been recognized within her academic and professional circles. In 2024, she is set to receive her qualification to practice as a biologist, marking a significant milestone in her professional development. Her research contributions have placed her in the spotlight for future awards and recognition in the field of molecular biology and stem cell research. Although her CV does not currently highlight specific awards, her consistent involvement in high-impact research projects, her PhD dissertation on stem cell dysfunctions, and her internships and research fellowships reflect a promising path toward earning significant honors in the years to come. Given her dedication to her field and her growing reputation, it is likely that Mariangela will receive further accolades as her research continues to make a lasting impact on the scientific community.

Conclusion

Mariangela Di Vincenzo is a promising candidate for the Best Researcher Award. Her focused, innovative research in stem cells and Cushing’s syndrome holds considerable promise for contributing to the field of human health. With her solid education, hands-on experience, and continuous involvement in significant research projects, she demonstrates a high level of scientific expertise. However, to further solidify her candidacy, focusing on increasing her publication record, broadening the reach of her work, and assuming leadership roles in her research group could make her an even more well-rounded and impactful researcher.

Publications Top Noted

  • Title: Monitoring cellular dynamics upon infection using a holotomography-based approach
  • Authors: Ilaria Nunzi, Gloria D’Achille, Nada Dhaouadi, Mariangela Di Vincenzo, Gianluca Morroni, Saverio Marchi, and others.
  • Year: The specific year of publication is not provided in your information, but you can visit the ORCID or Scopus profile to confirm.
  • Citations: 0 citations.

 

Sergey Deev | Genetics | Best Paper Award

Posted on by ScienceFather

Prof Dr. Sergey Deev | Genetics | Best Paper Award

Member of Russian Academy of Sciences, Member of Academia Europaea, Head of Molecular Immunology Laboratory, Russia

Dr. Sergey M. Deyev is a distinguished Professor and a full member of the Russian Academy of Sciences. Renowned for his contributions to molecular immunology, Dr. Deyev is currently the Deputy Chairman of the Expert Council for Biology at the Russian Foundation for Basic Research and leads the Molecular Immunology Laboratory at the Shemyakin & Ovchinnikov Institute of Bioorganic Chemistry. His career spans several decades, characterized by groundbreaking research in targeted cancer therapies and nanoparticle applications.

Profile

Scopus

Education 🎓:

Dr. Deyev completed his M.Sc. in Chemistry from Lomonosov Moscow State University in 1973, followed by a Ph.D. in Molecular Biology from the Engelhardt Institute of Molecular Biology in 1977. His Doctor of Science (D.Sc.) in Molecular Biology was awarded in 1990, with his thesis focusing on the structure and rearrangements of immunoglobulin genes.

Experience đź’Ľ:

Dr. Deyev has held prominent roles in academia and research institutions. Since 2000, he has served as the Head of the Molecular Immunology Laboratory at the Shemyakin & Ovchinnikov Institute. He also holds professorships at multiple prestigious institutions, including Lomonosov Moscow State University and the National Research Nuclear University “MEPhI.” His extensive experience includes positions as a visiting professor and researcher internationally, furthering his impact in molecular biology and immunology.

Research Interests 🔬:

Dr. Deyev’s research focuses on developing nanotechnology-based solutions for targeted cancer therapies, including using nanoparticles for diagnostic bioimaging and tumor treatment. His lab specializes in the targeted delivery of nano-agents, high-affinity protein complexes, and genetic engineering of recombinant proteins. He is recognized for discovering the barnase-barstar protein pair, which has applications in drug delivery and immunotherapy.

Awards 🏆:

Throughout his career, Dr. Deyev has received numerous honors, including the prestigious “For Merit to the Fatherland” medal in 2018, the Shemyakin Prize in 2016, and the Mechnikov Prize for contributions to immunology and biotechnology. His membership in Academia Europaea and the Russian Academy of Sciences underscores his significant influence in the scientific community.

Publications  Top Notes📚:

Dr. Deyev has co-authored many high-impact research papers, including recent notable publications:

“Flash drug release from nanoparticles accumulated in the targeted blood vessels facilitates the tumour treatment” in Nature Communications (2022) (DOI: 10.1038/s41467-022-34718-3), which has been cited for its contributions to advancing cancer treatment methodologies.

“Switchable targeting of solid tumors by BsCAR T cells” in Proceedings of the National Academy of Sciences USA (2022) (DOI: 10.1073/pnas.2210562119), noted for innovative approaches in T cell-mediated cancer targeting.